KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Cvs Health (CVS) Long-Term Debt Issuances (2018 - 2025)

Cvs Health (CVS) has disclosed Long-Term Debt Issuances for 10 consecutive years, with $4.0 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Issuances changed N/A year-over-year to $4.0 billion, compared with a TTM value of $6.9 billion through Dec 2025, down 12.51%, and an annual FY2025 reading of $4.0 billion, down 49.84% over the prior year.
  • Long-Term Debt Issuances was $4.0 billion for Q3 2025 at Cvs Health, up from $3.0 billion in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $6.0 billion in Q1 2023 and bottomed at $987.0 million in Q3 2021.
  • Average Long-Term Debt Issuances over 4 years is $4.0 billion, with a median of $4.5 billion recorded in 2023.
  • The sharpest move saw Long-Term Debt Issuances plummeted 75.16% in 2021, then grew 0.24% in 2024.
  • Year by year, Long-Term Debt Issuances stood at $987.0 million in 2021, then soared by 401.22% to $4.9 billion in 2023, then tumbled by 40.29% to $3.0 billion in 2024, then surged by 34.36% to $4.0 billion in 2025.
  • Business Quant data shows Long-Term Debt Issuances for CVS at $4.0 billion in Q3 2025, $3.0 billion in Q4 2024, and $5.0 billion in Q2 2024.